Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP270216.RAHy7oEf3QKTRdPu5sxDFHu5nR5oR10SD_tFVr0o5etpM130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP270216.RAHy7oEf3QKTRdPu5sxDFHu5nR5oR10SD_tFVr0o5etpM130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP270216.RAHy7oEf3QKTRdPu5sxDFHu5nR5oR10SD_tFVr0o5etpM130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP270216.RAHy7oEf3QKTRdPu5sxDFHu5nR5oR10SD_tFVr0o5etpM130_provenance.
- NP270216.RAHy7oEf3QKTRdPu5sxDFHu5nR5oR10SD_tFVr0o5etpM130_assertion description "[Of the 80 specimens of primary prostate cancer examined by receptor binding assays, 50 ( approximately 63%) showed high-affinity, low-capacity binding sites for bombesin/GRP, and 12 of these 50 receptor-positive specimens also showed a second binding site.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP270216.RAHy7oEf3QKTRdPu5sxDFHu5nR5oR10SD_tFVr0o5etpM130_provenance.
- NP270216.RAHy7oEf3QKTRdPu5sxDFHu5nR5oR10SD_tFVr0o5etpM130_assertion evidence source_evidence_literature NP270216.RAHy7oEf3QKTRdPu5sxDFHu5nR5oR10SD_tFVr0o5etpM130_provenance.
- NP270216.RAHy7oEf3QKTRdPu5sxDFHu5nR5oR10SD_tFVr0o5etpM130_assertion SIO_000772 10679759 NP270216.RAHy7oEf3QKTRdPu5sxDFHu5nR5oR10SD_tFVr0o5etpM130_provenance.
- NP270216.RAHy7oEf3QKTRdPu5sxDFHu5nR5oR10SD_tFVr0o5etpM130_assertion wasDerivedFrom befree-20140225 NP270216.RAHy7oEf3QKTRdPu5sxDFHu5nR5oR10SD_tFVr0o5etpM130_provenance.
- NP270216.RAHy7oEf3QKTRdPu5sxDFHu5nR5oR10SD_tFVr0o5etpM130_assertion wasGeneratedBy ECO_0000203 NP270216.RAHy7oEf3QKTRdPu5sxDFHu5nR5oR10SD_tFVr0o5etpM130_provenance.
- befree-20140225 importedOn "2014-02-25" NP270216.RAHy7oEf3QKTRdPu5sxDFHu5nR5oR10SD_tFVr0o5etpM130_provenance.